๐งช Solute Removal in Hemodialysis Diffusion ยท Convection ยท Adsorption
The three primary mechanisms of solute removal: diffusion, convection, and adsorption โ and their clinical implications for uremic toxin clearance
Solute removal in hemodialysis occurs through a combination of diffusion, convection, and adsorption. Uremic solutes are divided into three main categories: small water-soluble compounds (<500 Da, removed by any membrane via diffusion); middle molecules (500โ15,000 Da, require high-flux membranes); and protein-bound molecules (difficult to remove due to protein binding).
๐จ Diffusion
Primary mechanism for small solutes (urea, creatinine). Driven by concentration gradient across the membrane.
- Expressed as KoA (mass transfer coefficient ร surface area)
- Manufacturer provides KoA values for urea
- Critical note: In vitro KoA values should be reduced by ~20% to replicate in vivo conditions
- Manufacturer in vitro data must NOT be used directly in urea kinetics for prescription
๐ก KoA is dialyzer-specific and solute-specific โ the same dialyzer has different KoA for urea, creatinine, and phosphate.
๐ Convection
Bulk flow of solutes across the membrane driven by hydraulic pressure. Enhanced with high-flux dialyzers.
- Allows removal of middle molecules (500โ15,000 Da)
- Achieved through increased porosity and efficiency of mass transfer
- Separates solutes and low molecular weight proteins from large serum proteins
- Primary mechanism in hemofiltration and hemodiafiltration (HDF)
๐ฌ High-flux dialyzers utilize both diffusion and convection for enhanced middle molecule clearance.
๐งฒ Adsorption
Adhesion of macromolecules and proteins to the membrane surface without penetration. Depends on internal pore structure and membrane hydrophobicity.
- Enhances removal of protein-bound uremic toxins
- Negative consequence: Highly adsorptive membranes may reduce diffusive and convective capacities
- Ideal membrane: Moderate protein adsorption + ability to bind protein-bound uremic toxins
๐ Recommended feature: Moderate adsorption capacity balances toxin removal with preserved diffusive/convective performance.
๐ Urea & Phosphate Clearance
Clearance is the most important dialyzer characteristic โ critical factor in determining dialysis prescription.
- Urea clearance: Most commonly used measure, calculates dialysis dose (Kt/V)
- Phosphate clearance: Not always reported, but helpful for hyperphosphatemia
- Phosphate is intracellular: High phosphate clearance can cause rapid plasma decrease without major impact on total removal
- Uric acid clearance: Similarly helpful for hyperuricemia
โ ๏ธ Phosphate removal is time-dependent โ longer sessions are more effective than simply using a high-phosphate-clearance dialyzer.
๐ฌ ฮฒ2-Microglobulin (ฮฒ2M): Surrogate Marker for Middle Molecules
Enlarging membrane pore size beyond conventional low-flux dialyzers has led to increased ฮฒ2M clearance (11.8 kDa). Because it is easy to measure, ฮฒ2M is now a surrogate marker for middle molecular weight solutes. The membrane sieving coefficient for ฮฒ2M is accepted by manufacturers and the medical community.
๐ High-Flux Definition: Dialyzers are considered high-flux if:
- Ultrafiltration coefficient (Kuf) > 15 ml/h/mmHg
- ฮฒ2M clearance > 20 ml/min
๐ฏ๐ต Japanese Classification of Dialyzers (Based on ฮฒ2M Clearance)
| Type | ฮฒ2M Clearance (ml/min) | Classification | Cut-Off (Da) |
|---|---|---|---|
| Type I | < 10 | Low-flux | < 3,000 |
| Type II | 10โ30 | Conventional high-flux | ~5,000โ10,000 |
| Type III | 30โ50 | High-flux | ~15,000โ25,000 |
| Type IV | 50โ70 | Super high-flux | ~40,000โ50,000 |
| Type V | > 70 | Super high-flux | ~65,000 (kidney-like) |
๐ก Clinical significance: Types IV and V (super high-flux) have molecular weight cut-offs approaching the human kidney (65,000 Da), enabling efficient removal of middle/large uremic toxins and greater clearance of inflammatory cytokines than conventional high-flux membranes.
๐ Clinical Evidence: High-Flux vs Low-Flux Hemodialysis
Cochrane Review (3820 patients, all available RCTs)
- Could not determine overall efficacy and safety of high-flux vs low-flux HD
- Concluded: High-flux HD may reduce cardiovascular mortality by ~15% in people requiring HD
๐ HEMO Study (Hemodialysis Study)
- High-flux HD provided significantly lower rates for cardiac and cerebrovascular mortality after 3.7 years on HD compared to low-flux HD
๐ MPO Study (Membrane Permeability Outcome)
- High-flux HD provided higher survival rates for:
- Patients with serum albumin โค4 g/dL
- Diabetic patients
- Even low-risk patients
๐ Conclusion from major trials: High-flux hemodialysis is associated with reduced cardiovascular mortality, particularly in patients with low albumin or diabetes.
โ ๏ธ Safety Considerations: Backfiltration & Rapid Ultrafiltration
๐ Backfiltration โ Critical Safety Concern
- Backfiltration almost never occurs in low-flux dialysis
- Occurrence during high-flux treatments depends on transmembrane pressure (TMP)
- Forward and backfiltration coefficients differ in vitro and even more so in vivo due to:
- Protein layer in the blood compartment
- Membrane structure
- Any contamination of dialysate or washout from the membrane can reach the blood side
๐ Rapid Ultrafiltration Risks
- Correcting interdialytic weight gain >5 kg within a session <3 hours using high-flux dialysis can lead to significant hypotension risk
- Especially dangerous in patients with:
- Poor cardiac function
- Autonomic neuropathy
๐ Clinical Safety Pearls:
- Monitor TMP closely during high-flux treatments to prevent excessive backfiltration
- Use ultrapure dialysate for high-flux dialysis to minimize pyrogen exposure
- Limit ultrafiltration rate to โค10โ13 ml/kg/hour to reduce hypotension risk
- Consider longer or more frequent sessions for patients with large interdialytic weight gains
๐ Solute Categories & Removal Mechanisms
| Solute Category | Molecular Weight | Examples | Primary Removal Mechanism | Membrane Requirement |
|---|---|---|---|---|
| Small water-soluble | <500 Da | Urea, Creatinine, Uric acid, Electrolytes | Diffusion | Any membrane (low-flux sufficient) |
| Middle molecules | 500โ15,000 Da | ฮฒ2M (11.8 kDa), PTH, FGF-23, Myoglobin (17 kDa) | Convection + Diffusion | High-flux required |
| Protein-bound molecules | <500 Da (bound) | p-cresol sulfate, indoxyl sulfate, homocysteine | Adsorption + Convection | High-flux with adsorptive properties |
| Large molecules / cytokines | >15,000 Da | IL-6 (24 kDa), TNF-ฮฑ (26 kDa), Light chains | Convection (super high-flux) | Super high-flux / HDF |
ฮฒ2M = beta-2-microglobulin; PTH = parathyroid hormone; FGF-23 = fibroblast growth factor 23; HDF = hemodiafiltration
๐ง Clinical Takeaway:
- Small solutes (urea): Removed by diffusion โ use KoA for prescription (with 20% in vivo reduction)
- Middle molecules (ฮฒ2M): Require high-flux membranes โ ฮฒ2M clearance is the surrogate marker
- Protein-bound solutes: Require adsorption โ moderate adsorption capacity is optimal
- High-flux HD may reduce cardiovascular mortality by ~15% (Cochrane) and improves survival in diabetics and low-albumin patients (MPO study)
- Safety: Monitor TMP to prevent backfiltration; avoid rapid ultrafiltration (>5 kg in <3 hours) in high-risk patients
Dialyzer selection should integrate solute removal needs, patient comorbidities, and safety considerations for optimal outcomes.